Company Filing History:
Years Active: 2023-2024
Title: John Taylor: Innovator in Periodontitis Diagnostics
Introduction
John Taylor is a notable inventor based in Framlington Place, GB. He has made significant contributions to the field of periodontitis diagnostics, holding a total of 3 patents. His work focuses on innovative methods for assessing the severity of periodontitis in patients, which can lead to improved treatment options.
Latest Patents
One of Taylor's latest patents is a system for classifying periodontitis patients. This invention discloses a method for assessing whether a patient suffers from mild or advanced periodontitis. The system utilizes a clustering technique applied to a reference set of patient data, discriminating between sets of biomarkers. The classification is based on the measurement of concentrations of specific biomarkers, including Hepatocyte Growth Factor (HGF), Matrix metalloproteinase 8 (MMP8), and Matrix metalloproteinase 9 (MMP9).
Another significant patent involves the diagnostics of mild or advanced periodontitis based on salivary IL-1BETA and MMP-9. This in vitro method assesses the concentrations of proteins such as Interleukin-1β (IL-1β) and Matrix metalloproteinase-9 (MMP-9) in saliva samples. By comparing these concentrations to a threshold value, the method determines whether a patient has mild or advanced periodontitis.
Career Highlights
John Taylor is currently employed at Koninklijke Philips Corporation N.V., where he continues to innovate in the field of medical diagnostics. His work has the potential to significantly impact patient care and treatment outcomes for those suffering from periodontitis.
Collaborations
Throughout his career, Taylor has collaborated with notable colleagues, including Marinus Karel Johannes De Jager and Amir Hussein Rmaile. These collaborations have contributed to the advancement of his research and the development of his patents.
Conclusion
John Taylor is a distinguished inventor whose work in periodontitis diagnostics is paving the way for more effective patient assessments and treatments. His innovative patents reflect a commitment to improving healthcare outcomes through scientific advancements.